APO Research

APO RESEARCH · REPORT

Megestrol Acetate (Megace)

Selected research

Market Structure

Global Megestrol Acetate (Megace) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Megestrol Acetate (Megace) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Megestrol Acetate (Megace) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Megestrol Acetate (Megace) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Megestrol Acetate (Megace) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Megestrol Acetate (Megace) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Megestrol Acetate (Megace) include Actiza Pharmaceutical, Apotex Corporation, Breckenridge Pharmaceutical, Hikma (West-ward Pharm, Roxane Labs..), Hi-tech Pharmacal (Akorn), Morton Grove Pharmaceutical, Par Pharmaceutical (Endo International), TWi Pharmaceuticals and Jiangsu Nhwa Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Megestrol Acetate (Megace) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Megestrol Acetate (Megace) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Megestrol Acetate (Megace) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Megestrol Acetate (Megace) market size, projected growth trends, production technologies, key applications, and end-use industries.

Megestrol Acetate (Megace) Segment by Company

Actiza Pharmaceutical

Apotex Corporation

Breckenridge Pharmaceutical

Hikma (West-ward Pharm, Roxane Labs..)

Hi-tech Pharmacal (Akorn)

Morton Grove Pharmaceutical

Par Pharmaceutical (Endo International)

TWi Pharmaceuticals

Jiangsu Nhwa Pharmaceutical

Nanjing Cuccess Pharmaceutical

Qingdao Guohai Biological Pharmaceutical

Teva Pharmaceuticals

Grand Deten Pharmaceutical

Xianju pharma

Megestrol Acetate (Megace) Segment by Type

Suspension

Tablets

Megestrol Acetate (Megace) Segment by Application

Hospital

Clinic

Other

Megestrol Acetate (Megace) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Megestrol Acetate (Megace) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Megestrol Acetate (Megace) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Megestrol Acetate (Megace).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Megestrol Acetate (Megace) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Megestrol Acetate (Megace) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Megestrol Acetate (Megace) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Megestrol Acetate (Megace) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Megestrol Acetate (Megace) Industry Trends Table 2. Megestrol Acetate (Megace) Industry Drivers Table 3. Megestrol Acetate (Megace) Industry Opportunities and Challenges Table 4. Megestrol Acetate (Megace) Industry Restraints Table 5. Global Megestrol Acetate (Megace) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Megestrol Acetate (Megace) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Megestrol Acetate (Megace) Sales by Manufacturers (Units) & (2021-2026) Table 8. Global Megestrol Acetate (Megace) Sales Market Share by Manufacturers Table 9. Global Megestrol Acetate (Megace) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Megestrol Acetate (Megace) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Megestrol Acetate (Megace) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Megestrol Acetate (Megace) Manufacturers, Product Type & Application Table 13. Global Megestrol Acetate (Megace) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Megestrol Acetate (Megace) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Suspension Table 17. Major Manufacturers of Tablets Table 18. Global Megestrol Acetate (Megace) Sales by Type 2021 VS 2025 VS 2032 (Units) Table 19. Global Megestrol Acetate (Megace) Sales by Type (2021-2026) & (Units) Table 20. Global Megestrol Acetate (Megace) Sales by Type (2027-2032) & (Units) Table 21. Global Megestrol Acetate (Megace) Sales Market Share by Type (2021-2026) Table 22. Global Megestrol Acetate (Megace) Sales Market Share by Type (2027-2032) Table 23. Global Megestrol Acetate (Megace) Revenue by Type 2021 VS 2025 VS 2032 (Units) Table 24. Global Megestrol Acetate (Megace) Revenue by Type (2021-2026) & (Units) Table 25. Global Megestrol Acetate (Megace) Revenue by Type (2027-2032) & (Units) Table 26. Global Megestrol Acetate (Megace) Revenue Market Share by Type (2021-2026) Table 27. Global Megestrol Acetate (Megace) Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global Megestrol Acetate (Megace) Sales by Application 2021 VS 2025 VS 2032 (Units) Table 32. Global Megestrol Acetate (Megace) Sales by Application (2021-2026) & (Units) Table 33. Global Megestrol Acetate (Megace) Sales by Application (2027-2032) & (Units) Table 34. Global Megestrol Acetate (Megace) Sales Market Share by Application (2021-2026) Table 35. Global Megestrol Acetate (Megace) Sales Market Share by Application (2027-2032) Table 36. Global Megestrol Acetate (Megace) Revenue by Application 2021 VS 2025 VS 2032 (Units) Table 37. Global Megestrol Acetate (Megace) Revenue by Application (2021-2026) & (Units) Table 38. Global Megestrol Acetate (Megace) Revenue by Application (2027-2032) & (Units) Table 39. Global Megestrol Acetate (Megace) Revenue Market Share by Application (2021-2026) Table 40. Global Megestrol Acetate (Megace) Revenue Market Share by Application (2027-2032) Table 41. Global Megestrol Acetate (Megace) Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 42. Global Megestrol Acetate (Megace) Sales by Region (2021-2026) & (Units) Table 43. Global Megestrol Acetate (Megace) Sales Market Share by Region (2021-2026) Table 44. Global Megestrol Acetate (Megace) Sales Forecasted by Region (2027-2032) & (Units) Table 45. Global Megestrol Acetate (Megace) Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Megestrol Acetate (Megace) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 47. North America Megestrol Acetate (Megace) Sales by Country (2021-2026) & (Units) Table 48. North America Megestrol Acetate (Megace) Sales by Country (2027-2032) & (Units) Table 49. Europe Megestrol Acetate (Megace) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 50. Europe Megestrol Acetate (Megace) Sales by Country (2021-2026) & (Units) Table 51. Europe Megestrol Acetate (Megace) Sales by Country (2027-2032) & (Units) Table 52. Asia Pacific Megestrol Acetate (Megace) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 53. Asia Pacific Megestrol Acetate (Megace) Sales by Country (2021-2026) & (Units) Table 54. Asia Pacific Megestrol Acetate (Megace) Sales by Country (2027-2032) & (Units) Table 55. South America, Middle East and Africa Megestrol Acetate (Megace) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 56. South America, Middle East and Africa Megestrol Acetate (Megace) Sales by Country (2021-2026) & (Units) Table 57. South America, Middle East and Africa Megestrol Acetate (Megace) Sales by Country (2027-2032) & (Units) Table 58. Global Megestrol Acetate (Megace) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Megestrol Acetate (Megace) Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Megestrol Acetate (Megace) Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Megestrol Acetate (Megace) Revenue Market Share by Region (2021-2026) Table 62. Global Megestrol Acetate (Megace) Revenue Market Share by Region (2027-2032) Table 63. Actiza Pharmaceutical Company Information Table 64. Actiza Pharmaceutical Business Overview Table 65. Actiza Pharmaceutical Megestrol Acetate (Megace) Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Actiza Pharmaceutical Megestrol Acetate (Megace) Product Portfolio Table 67. Actiza Pharmaceutical Recent Development Table 68. Apotex Corporation Company Information Table 69. Apotex Corporation Business Overview Table 70. Apotex Corporation Megestrol Acetate (Megace) Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Apotex Corporation Megestrol Acetate (Megace) Product Portfolio Table 72. Apotex Corporation Recent Development Table 73. Breckenridge Pharmaceutical Company Information Table 74. Breckenridge Pharmaceutical Business Overview Table 75. Breckenridge Pharmaceutical Megestrol Acetate (Megace) Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Breckenridge Pharmaceutical Megestrol Acetate (Megace) Product Portfolio Table 77. Breckenridge Pharmaceutical Recent Development Table 78. Hikma (West-ward Pharm, Roxane Labs..) Company Information Table 79. Hikma (West-ward Pharm, Roxane Labs..) Business Overview Table 80. Hikma (West-ward Pharm, Roxane Labs..) Megestrol Acetate (Megace) Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Hikma (West-ward Pharm, Roxane Labs..) Megestrol Acetate (Megace) Product Portfolio Table 82. Hikma (West-ward Pharm, Roxane Labs..) Recent Development Table 83. Hi-tech Pharmacal (Akorn) Company Information Table 84. Hi-tech Pharmacal (Akorn) Business Overview Table 85. Hi-tech Pharmacal (Akorn) Megestrol Acetate (Megace) Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Hi-tech Pharmacal (Akorn) Megestrol Acetate (Megace) Product Portfolio Table 87. Hi-tech Pharmacal (Akorn) Recent Development Table 88. Morton Grove Pharmaceutical Company Information Table 89. Morton Grove Pharmaceutical Business Overview Table 90. Morton Grove Pharmaceutical Megestrol Acetate (Megace) Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Morton Grove Pharmaceutical Megestrol Acetate (Megace) Product Portfolio Table 92. Morton Grove Pharmaceutical Recent Development Table 93. Par Pharmaceutical (Endo International) Company Information Table 94. Par Pharmaceutical (Endo International) Business Overview Table 95. Par Pharmaceutical (Endo International) Megestrol Acetate (Megace) Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Par Pharmaceutical (Endo International) Megestrol Acetate (Megace) Product Portfolio Table 97. Par Pharmaceutical (Endo International) Recent Development Table 98. TWi Pharmaceuticals Company Information Table 99. TWi Pharmaceuticals Business Overview Table 100. TWi Pharmaceuticals Megestrol Acetate (Megace) Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. TWi Pharmaceuticals Megestrol Acetate (Megace) Product Portfolio Table 102. TWi Pharmaceuticals Recent Development Table 103. Jiangsu Nhwa Pharmaceutical Company Information Table 104. Jiangsu Nhwa Pharmaceutical Business Overview Table 105. Jiangsu Nhwa Pharmaceutical Megestrol Acetate (Megace) Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Jiangsu Nhwa Pharmaceutical Megestrol Acetate (Megace) Product Portfolio Table 107. Jiangsu Nhwa Pharmaceutical Recent Development Table 108. Nanjing Cuccess Pharmaceutical Company Information Table 109. Nanjing Cuccess Pharmaceutical Business Overview Table 110. Nanjing Cuccess Pharmaceutical Megestrol Acetate (Megace) Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Nanjing Cuccess Pharmaceutical Megestrol Acetate (Megace) Product Portfolio Table 112. Nanjing Cuccess Pharmaceutical Recent Development Table 113. Qingdao Guohai Biological Pharmaceutical Company Information Table 114. Qingdao Guohai Biological Pharmaceutical Business Overview Table 115. Qingdao Guohai Biological Pharmaceutical Megestrol Acetate (Megace) Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Qingdao Guohai Biological Pharmaceutical Megestrol Acetate (Megace) Product Portfolio Table 117. Qingdao Guohai Biological Pharmaceutical Recent Development Table 118. Teva Pharmaceuticals Company Information Table 119. Teva Pharmaceuticals Business Overview Table 120. Teva Pharmaceuticals Megestrol Acetate (Megace) Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Teva Pharmaceuticals Megestrol Acetate (Megace) Product Portfolio Table 122. Teva Pharmaceuticals Recent Development Table 123. Grand Deten Pharmaceutical Company Information Table 124. Grand Deten Pharmaceutical Business Overview Table 125. Grand Deten Pharmaceutical Megestrol Acetate (Megace) Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Grand Deten Pharmaceutical Megestrol Acetate (Megace) Product Portfolio Table 127. Grand Deten Pharmaceutical Recent Development Table 128. Xianju pharma Company Information Table 129. Xianju pharma Business Overview Table 130. Xianju pharma Megestrol Acetate (Megace) Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Xianju pharma Megestrol Acetate (Megace) Product Portfolio Table 132. Xianju pharma Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Megestrol Acetate (Megace) Distributors List Table 136. Megestrol Acetate (Megace) Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Megestrol Acetate (Megace) Product Image Figure 2. Global Megestrol Acetate (Megace) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Megestrol Acetate (Megace) Market Size (2021-2032) & (US$ Million) Figure 4. Global Megestrol Acetate (Megace) Sales (2021-2032) & (Units) Figure 5. Global Megestrol Acetate (Megace) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Megestrol Acetate (Megace) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Suspension Image Figure 9. Tablets Image Figure 10. Global Megestrol Acetate (Megace) Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 11. Global Megestrol Acetate (Megace) Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Megestrol Acetate (Megace) Sales Market Share by Type (2021-2032) Figure 13. Global Megestrol Acetate (Megace) Revenue by Type (2021 VS 2025 VS 2032) & (Units) Figure 14. Global Megestrol Acetate (Megace) Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Megestrol Acetate (Megace) Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Megestrol Acetate (Megace) Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 20. Global Megestrol Acetate (Megace) Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Megestrol Acetate (Megace) Sales Market Share by Application (2021-2032) Figure 22. Global Megestrol Acetate (Megace) Revenue by Application (2021 VS 2025 VS 2032) & (Units) Figure 23. Global Megestrol Acetate (Megace) Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Megestrol Acetate (Megace) Revenue Market Share by Application (2021-2032) Figure 25. North America Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 26. North America Megestrol Acetate (Megace) Sales Market Share by Country (2021-2032) Figure 27. U.S. Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 28. Canada Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 29. Mexico Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 30. Europe Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 31. Europe Megestrol Acetate (Megace) Sales Market Share by Country (2021-2032) Figure 32. Germany Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 33. France Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 34. U.K. Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 35. Italy Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 36. Netherlands Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 37. Asia Pacific Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 38. Asia Pacific Megestrol Acetate (Megace) Sales Market Share by Country (2021-2032) Figure 39. China Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 40. Japan Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 41. South Korea Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 42. Southeast Asia Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 43. India Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 44. Australia Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 45. South America, Middle East and Africa Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 46. South America, Middle East and Africa Megestrol Acetate (Megace) Sales Market Share by Country (2021-2032) Figure 47. Brazil Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 48. South Africa Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 49. Saudi Arabia Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 50. Turkey Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 51. Argentina Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 52. UAE Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 53. Egypt Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 54. Chile Megestrol Acetate (Megace) Sales and Growth Rate (2021-2032) & (Units) Figure 55. Global Megestrol Acetate (Megace) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Megestrol Acetate (Megace) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Megestrol Acetate (Megace) Revenue (2021-2032) & (US$ Million) Figure 58. North America Megestrol Acetate (Megace) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Megestrol Acetate (Megace) Revenue (2021-2032) & (US$ Million) Figure 60. Europe Megestrol Acetate (Megace) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Megestrol Acetate (Megace) Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Megestrol Acetate (Megace) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Megestrol Acetate (Megace) Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Megestrol Acetate (Megace) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Megestrol Acetate (Megace) Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Megestrol Acetate (Megace) Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Suspension
  • Tablets
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Actiza Pharmaceutical
  • Apotex Corporation
  • Breckenridge Pharmaceutical
  • Hikma (West-ward Pharm, Roxane Labs..)
  • Hi-tech Pharmacal (Akorn)
  • Morton Grove Pharmaceutical
  • Par Pharmaceutical (Endo International)
  • TWi Pharmaceuticals
  • Jiangsu Nhwa Pharmaceutical
  • Nanjing Cuccess Pharmaceutical
  • Qingdao Guohai Biological Pharmaceutical
  • Teva Pharmaceuticals
  • Grand Deten Pharmaceutical
  • Xianju pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Megestrol Acetate (Megace) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Megestrol Acetate (Megace) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Megestrol Acetate (Megace) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Megestrol Acetate (Megace) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Megestrol Acetate (Megace) Market Dynamics
  1. 2.1 Megestrol Acetate (Megace) Industry Trends
  2. 2.2 Megestrol Acetate (Megace) Industry Drivers
  3. 2.3 Megestrol Acetate (Megace) Industry Opportunities and Challenges
  4. 2.4 Megestrol Acetate (Megace) Industry Restraints
3 Megestrol Acetate (Megace) Market by Manufacturers
  1. 3.1 Global Megestrol Acetate (Megace) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Megestrol Acetate (Megace) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Megestrol Acetate (Megace) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Megestrol Acetate (Megace) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Megestrol Acetate (Megace) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Megestrol Acetate (Megace) Manufacturers, Product Type & Application
  7. 3.7 Global Megestrol Acetate (Megace) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Megestrol Acetate (Megace) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Megestrol Acetate (Megace) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Megestrol Acetate (Megace) Tier 1, Tier 2, and Tier 3
4 Megestrol Acetate (Megace) Market by Type
  1. 4.1 Megestrol Acetate (Megace) Type Introduction
  2. 4.1.1 Suspension
  3. 4.1.2 Tablets
  4. 4.2 Global Megestrol Acetate (Megace) Sales by Type
  5. 4.2.1 Global Megestrol Acetate (Megace) Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Megestrol Acetate (Megace) Sales by Type (2021-2032)
  7. 4.2.3 Global Megestrol Acetate (Megace) Sales Market Share by Type (2021-2032)
  8. 4.3 Global Megestrol Acetate (Megace) Revenue by Type
  9. 4.3.1 Global Megestrol Acetate (Megace) Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Megestrol Acetate (Megace) Revenue by Type (2021-2032)
  11. 4.3.3 Global Megestrol Acetate (Megace) Revenue Market Share by Type (2021-2032)
5 Megestrol Acetate (Megace) Market by Application
  1. 5.1 Megestrol Acetate (Megace) Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Megestrol Acetate (Megace) Sales by Application
  6. 5.2.1 Global Megestrol Acetate (Megace) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Megestrol Acetate (Megace) Sales by Application (2021-2032)
  8. 5.2.3 Global Megestrol Acetate (Megace) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Megestrol Acetate (Megace) Revenue by Application
  10. 5.3.1 Global Megestrol Acetate (Megace) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Megestrol Acetate (Megace) Revenue by Application (2021-2032)
  12. 5.3.3 Global Megestrol Acetate (Megace) Revenue Market Share by Application (2021-2032)
6 Global Megestrol Acetate (Megace) Sales by Region
  1. 6.1 Global Megestrol Acetate (Megace) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Megestrol Acetate (Megace) Sales by Region (2021-2032)
  3. 6.2.1 Global Megestrol Acetate (Megace) Sales by Region (2021-2026)
  4. 6.2.2 Global Megestrol Acetate (Megace) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Megestrol Acetate (Megace) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Megestrol Acetate (Megace) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Megestrol Acetate (Megace) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Megestrol Acetate (Megace) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Megestrol Acetate (Megace) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Megestrol Acetate (Megace) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Megestrol Acetate (Megace) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Megestrol Acetate (Megace) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Megestrol Acetate (Megace) Revenue by Region
  1. 7.1 Global Megestrol Acetate (Megace) Revenue by Region
  2. 7.1.1 Global Megestrol Acetate (Megace) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Megestrol Acetate (Megace) Revenue by Region (2021-2026)
  4. 7.1.3 Global Megestrol Acetate (Megace) Revenue by Region (2027-2032)
  5. 7.1.4 Global Megestrol Acetate (Megace) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Megestrol Acetate (Megace) Revenue (2021-2032)
  8. 7.2.2 North America Megestrol Acetate (Megace) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Megestrol Acetate (Megace) Revenue (2021-2032)
  11. 7.3.2 Europe Megestrol Acetate (Megace) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Megestrol Acetate (Megace) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Megestrol Acetate (Megace) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Megestrol Acetate (Megace) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Megestrol Acetate (Megace) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Actiza Pharmaceutical
  2. 8.1.1 Actiza Pharmaceutical Company Information
  3. 8.1.2 Actiza Pharmaceutical Business Overview
  4. 8.1.3 Actiza Pharmaceutical Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Actiza Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
  6. 8.1.5 Actiza Pharmaceutical Recent Developments
  7. 8.2 Apotex Corporation
  8. 8.2.1 Apotex Corporation Company Information
  9. 8.2.2 Apotex Corporation Business Overview
  10. 8.2.3 Apotex Corporation Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Apotex Corporation Megestrol Acetate (Megace) Product Portfolio
  12. 8.2.5 Apotex Corporation Recent Developments
  13. 8.3 Breckenridge Pharmaceutical
  14. 8.3.1 Breckenridge Pharmaceutical Company Information
  15. 8.3.2 Breckenridge Pharmaceutical Business Overview
  16. 8.3.3 Breckenridge Pharmaceutical Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Breckenridge Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
  18. 8.3.5 Breckenridge Pharmaceutical Recent Developments
  19. 8.4 Hikma (West-ward Pharm, Roxane Labs..)
  20. 8.4.1 Hikma (West-ward Pharm, Roxane Labs..) Company Information
  21. 8.4.2 Hikma (West-ward Pharm, Roxane Labs..) Business Overview
  22. 8.4.3 Hikma (West-ward Pharm, Roxane Labs..) Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hikma (West-ward Pharm, Roxane Labs..) Megestrol Acetate (Megace) Product Portfolio
  24. 8.4.5 Hikma (West-ward Pharm, Roxane Labs..) Recent Developments
  25. 8.5 Hi-tech Pharmacal (Akorn)
  26. 8.5.1 Hi-tech Pharmacal (Akorn) Company Information
  27. 8.5.2 Hi-tech Pharmacal (Akorn) Business Overview
  28. 8.5.3 Hi-tech Pharmacal (Akorn) Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hi-tech Pharmacal (Akorn) Megestrol Acetate (Megace) Product Portfolio
  30. 8.5.5 Hi-tech Pharmacal (Akorn) Recent Developments
  31. 8.6 Morton Grove Pharmaceutical
  32. 8.6.1 Morton Grove Pharmaceutical Company Information
  33. 8.6.2 Morton Grove Pharmaceutical Business Overview
  34. 8.6.3 Morton Grove Pharmaceutical Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Morton Grove Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
  36. 8.6.5 Morton Grove Pharmaceutical Recent Developments
  37. 8.7 Par Pharmaceutical (Endo International)
  38. 8.7.1 Par Pharmaceutical (Endo International) Company Information
  39. 8.7.2 Par Pharmaceutical (Endo International) Business Overview
  40. 8.7.3 Par Pharmaceutical (Endo International) Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Par Pharmaceutical (Endo International) Megestrol Acetate (Megace) Product Portfolio
  42. 8.7.5 Par Pharmaceutical (Endo International) Recent Developments
  43. 8.8 TWi Pharmaceuticals
  44. 8.8.1 TWi Pharmaceuticals Company Information
  45. 8.8.2 TWi Pharmaceuticals Business Overview
  46. 8.8.3 TWi Pharmaceuticals Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 TWi Pharmaceuticals Megestrol Acetate (Megace) Product Portfolio
  48. 8.8.5 TWi Pharmaceuticals Recent Developments
  49. 8.9 Jiangsu Nhwa Pharmaceutical
  50. 8.9.1 Jiangsu Nhwa Pharmaceutical Company Information
  51. 8.9.2 Jiangsu Nhwa Pharmaceutical Business Overview
  52. 8.9.3 Jiangsu Nhwa Pharmaceutical Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Jiangsu Nhwa Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
  54. 8.9.5 Jiangsu Nhwa Pharmaceutical Recent Developments
  55. 8.10 Nanjing Cuccess Pharmaceutical
  56. 8.10.1 Nanjing Cuccess Pharmaceutical Company Information
  57. 8.10.2 Nanjing Cuccess Pharmaceutical Business Overview
  58. 8.10.3 Nanjing Cuccess Pharmaceutical Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nanjing Cuccess Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
  60. 8.10.5 Nanjing Cuccess Pharmaceutical Recent Developments
  61. 8.11 Qingdao Guohai Biological Pharmaceutical
  62. 8.11.1 Qingdao Guohai Biological Pharmaceutical Company Information
  63. 8.11.2 Qingdao Guohai Biological Pharmaceutical Business Overview
  64. 8.11.3 Qingdao Guohai Biological Pharmaceutical Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Qingdao Guohai Biological Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
  66. 8.11.5 Qingdao Guohai Biological Pharmaceutical Recent Developments
  67. 8.12 Teva Pharmaceuticals
  68. 8.12.1 Teva Pharmaceuticals Company Information
  69. 8.12.2 Teva Pharmaceuticals Business Overview
  70. 8.12.3 Teva Pharmaceuticals Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Teva Pharmaceuticals Megestrol Acetate (Megace) Product Portfolio
  72. 8.12.5 Teva Pharmaceuticals Recent Developments
  73. 8.13 Grand Deten Pharmaceutical
  74. 8.13.1 Grand Deten Pharmaceutical Company Information
  75. 8.13.2 Grand Deten Pharmaceutical Business Overview
  76. 8.13.3 Grand Deten Pharmaceutical Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Grand Deten Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
  78. 8.13.5 Grand Deten Pharmaceutical Recent Developments
  79. 8.14 Xianju pharma
  80. 8.14.1 Xianju pharma Company Information
  81. 8.14.2 Xianju pharma Business Overview
  82. 8.14.3 Xianju pharma Megestrol Acetate (Megace) Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Xianju pharma Megestrol Acetate (Megace) Product Portfolio
  84. 8.14.5 Xianju pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Megestrol Acetate (Megace) Value Chain Analysis
  2. 9.1.1 Megestrol Acetate (Megace) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Megestrol Acetate (Megace) Production Mode & Process
  6. 9.2 Megestrol Acetate (Megace) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Megestrol Acetate (Megace) Distributors
  9. 9.2.3 Megestrol Acetate (Megace) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research